Effect of intravenous aminophylline on post- spinal anesthesia headache in women under cesarean section

The effect of intravenous aminophylline on post- spinal anesthesia headache in women under cesarean section

Clinical practice with control and intervention group, with parallel groups, simple randomized triple blind

In this clinical trial study in Ninth Diabetes Hospital in 1397, each patient was enrolled by an anesthetist after an appointment and then examined for exit criteria. Then, the researcher will prescribe one of the two drugs based on the previously prepared randomized form and the nurse is not known to have any type of drug. For patients who are eligible, the pain questionnaire is filled up before and after 24 hours.

Entry Requirement: Satisfaction to participate in the study Subjected to cesarean section with spinal anesthesia No history of sensitivity to aminophylline or other xanthine derivatives with accurate history from them. Age 45-18 years Lack of history of migraine headaches, coagulation disorders, gestational toxicity, diabetes, seizure, smoking and narcotics, and cardiovascular diseases Conditions for not admitting to study: Performing a retinal anxiety Unwillingness to cooperate in the study General anesthesia Use of xanthine derivatives during the study

Patients in both intervention and control groups randomly received aminophylline and normal serum saline (0.09%) and normal serum saline (0.09%).

Headache

Available sampling from all women candidates for cesarean section with spinal anesthesia referred to Razi Torbat Heydarieh Hospital and Allameh Bhlol Gonabadi Hospital in Gonabad city, after being eligible for inclusion criteria by random allocation method using blocks Reversal, so that the number 1 as an intervention group (the group receiving aminophylline 3 mg based on the ideal body weight and 500 ml normal saline 0.9% venous) and the number 2 as the control group (receiving group 500 C C is considered to be 0.9% venous saline), and 4-block blocks (eg 2121) in the theme

In this study, the patients in the intervention group, after obtaining informed consent and entering the study, are not aware of which amniotic fluid injectable serum are available. Also, the clinical caregiver of the intervention group is unaware. Only the researcher has prepared the serum and the name of the patient in the intervention group and It will provide control to the clinical care provider for infusion, as well as assessing the outcome of the pain, the clinician will do without the knowledge of the intervention and control group.